The goodpasture autoantigen -: Identification of multiple cryptic epitopes on the NC1 domain of the α3(IV) collagen chain

被引:106
作者
Borza, DB
Netzer, KO
Leinonen, A
Todd, P
Cervera, J
Saus, J
Hudson, BG
机构
[1] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA
[2] Inst Invest Citol, Fdn Valenciana Invest Biomed, Valencia 46010, Spain
关键词
D O I
10.1074/jbc.275.8.6030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Goodpasture (GP) disease is an autoimmune disorder in which autoantibodies against the alpha 3(TV) chain of type TV collagen bind to the glomerular and alveolar basement membranes, causing progressive glomerulonephritis and pulmonary hemorrhage, Two major conformational epitope regions have been identified on the noncollagenous domain of type IV collagen (NC1 domain) of the alpha 3(IV) chain as residues 17-31 (E-A) and 127-141 (E-B) (Netzer, K.-O. et al. (1999) J. Biol. Chem. 274, 11267-11274), To determine whether these regions are two distinct epitopes or form a single epitope, three GP sera were fractionated by affinity chromatography on immobilized NC1 chimeras containing the E-A and/or the E-B region. Four subpopulations of GP antibodies with distinct epitope specificity for the alpha 3(IV)NC1 domain were thus separated and characterized. They were designated GP(A), GP(B), GP(AB) and GP(X), to reflect their reactivity with E-A only, E-B only, both regions, and neither, respectively. Hence, regions E-A and E-B encompass critical amino acids that constitute three distinct epitopes for GP(A), GP(B), and GP(AB) antibodies, respectively, whereas the epitope for GP, antibodies is located in a different unknown region. The GP(A) antibodies were consistently immunodominant, accounting for 60-65% of the total immunoreactivity to alpha 3(IV)NC1; thus, they probably play a major role in pathogenesis. Regions E-A and E-B are held in close proximity because they jointly form the epitope for Mab3, a monoclonal antibody that competes for binding with GP autoantibodies. All GP epitopes are sequestered in the hexamer configuration of the NC1 domain found in tissues and are inaccessible for antibody binding unless dissociation of the hexamer occurs, suggesting a possible mechanism for etiology of GP disease. GP antibodies have the capacity to extract alpha 3(IV)NC1 monomers, but not dimers, from native human glomerular basement membrane hexamers, a property that may be of fundamental importance for the pathogenesis of the disease.
引用
收藏
页码:6030 / 6037
页数:8
相关论文
共 29 条
[1]   Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation [J].
Brainwood, D ;
Kashtan, C ;
Gubler, MC ;
Turner, AN .
KIDNEY INTERNATIONAL, 1998, 53 (03) :762-766
[2]  
BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874
[3]   Identification of post-transplant anti-alpha 5(IV) collagen alloantibodies in X-linked Alport syndrome [J].
Dehan, P ;
VandenHeuvel, LPWJ ;
Smeets, HJM ;
Tryggvason, K ;
Foidart, JM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (10) :1983-1988
[4]   Sera from patients with anti-GEM nephritis including Goodpasture syndrome show heterogenous reactivity to recombinant NC1 domain of type IV collagen alpha chains [J].
Dehan, P ;
Weber, M ;
Zhang, X ;
Reeders, ST ;
Foidart, JM ;
Tryggvason, K .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (11) :2215-2222
[5]   A MONOCLONAL-ANTIBODY MARKER FOR ALPORT SYNDROME IDENTIFIES THE ALPORT ANTIGEN AS THE ALPHA-5 CHAIN OF TYPE-IV COLLAGEN [J].
DING, J ;
KASHTAN, CE ;
FAN, WW ;
KLEPPEL, MM ;
SUN, MJ ;
KALLURI, R ;
NEILSON, EG ;
MICHAEL, AF .
KIDNEY INTERNATIONAL, 1994, 45 (05) :1504-1506
[6]   Glomerular basement membrane -: Identification of a novel disulfide-cross-linked network of α3, α4, and α5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome [J].
Gunwar, S ;
Ballester, F ;
Noelken, ME ;
Sado, Y ;
Ninomiya, Y ;
Hudson, BG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8767-8775
[7]  
HARLOW E, 1988, ANTIBODIES LABORATOR, P311
[8]   CHARACTERIZATION OF ANTI-GBM ANTIBODIES INVOLVED IN GOODPASTURES-SYNDROME [J].
HELLMARK, T ;
JOHANSSON, C ;
WIESLANDER, J .
KIDNEY INTERNATIONAL, 1994, 46 (03) :823-829
[9]   Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease [J].
Hellmark, T ;
Segelmark, M ;
Unger, C ;
Burkhardt, H ;
Saus, J ;
Wieslander, J .
KIDNEY INTERNATIONAL, 1999, 55 (03) :936-944
[10]   THE PATHOGENESIS OF ALPORT SYNDROME INVOLVES TYPE-IV COLLAGEN MOLECULES CONTAINING THE ALPHA-3(IV) CHAIN - EVIDENCE FROM ANTI-GBM NEPHRITIS AFTER RENAL-TRANSPLANTATION [J].
HUDSON, BG ;
KALLURI, R ;
GUNWAR, S ;
WEBER, M ;
BALLESTER, F ;
HUDSON, JK ;
NOELKEN, ME ;
SARRAS, M ;
RICHARDSON, WR ;
SAUS, J ;
ABRAHAMSON, DR ;
GLICK, AD ;
HARALSON, MA ;
HELDERMAN, JH ;
STONE, WJ ;
JACOBSON, HR .
KIDNEY INTERNATIONAL, 1992, 42 (01) :179-187